quin2 has been researched along with phorbol-12,13-didecanoate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiki, H; Imanishi, Y; Kimura, S; Morino, A; Nam, KY | 1 |
| Feinstein, MB; Halenda, SP; Sha'afi, RI; Zavoico, GB | 1 |
2 other study(ies) available for quin2 and phorbol-12,13-didecanoate
| Article | Year |
|---|---|
Modulation of phospholipase A2 activity by the tumour promoters phorbol esters and teleocidin.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Aminoquinolines; Animals; Calcium; Carcinogens; Fluoresceins; Fluorescent Dyes; Hydrolysis; Liposomes; Lyngbya Toxins; Pancreas; Phorbol Esters; Phospholipases; Phospholipases A; Phospholipases A2; Spectrometry, Fluorescence; Swine; Tetradecanoylphorbol Acetate | 1990 |
Phorbol myristate acetate inhibits thrombin-stimulated Ca2+ mobilization and phosphatidylinositol 4,5-bisphosphate hydrolysis in human platelets.
Topics: Aminoquinolines; Blood Platelets; Calcimycin; Calcium; Humans; Lipid Metabolism; Phorbol Esters; Phorbols; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositols; Tetradecanoylphorbol Acetate; Thrombin | 1985 |